BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1857142)

  • 21. Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
    Palandri F; Castagnetti F; Testoni N; Luatti S; Marzocchi G; Bassi S; Breccia M; Alimena G; Pungolino E; Rege-Cambrin G; Varaldo R; Miglino M; Specchia G; Zuffa E; Ferrara F; Bocchia M; Saglio G; Pane F; Alberti D; Martinelli G; Baccarani M; Rosti G;
    Haematologica; 2008 Dec; 93(12):1792-6. PubMed ID: 18838477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reversion to chronic phase of chronic myelogenous leukemia in blast crisis with small-dose daunorubicin and oral prednisolone].
    Kuyama J; Take H
    Rinsho Ketsueki; 1995 Dec; 36(12):1353-8. PubMed ID: 8587171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of immunophenotyping in characterisation of blast crisis of chronic myeloid leukemia--a study of 25 cases.
    Padmanabhan V; Varma N; Dash S; Varma S
    Indian J Pathol Microbiol; 1996 Jan; 39(1):13-7. PubMed ID: 8755126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis.
    Soupir CP; Vergilio JA; Dal Cin P; Muzikansky A; Kantarjian H; Jones D; Hasserjian RP
    Am J Clin Pathol; 2007 Apr; 127(4):642-50. PubMed ID: 17369142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic myelogenous leukemia characterized by successive lymphoid and myelomonocytic blast crises].
    Shirai T; Hasegawa S; Niitani K; Nishimura T; Ishida H; Shinohara T
    Rinsho Ketsueki; 1989 May; 30(5):668-73. PubMed ID: 2795881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
    Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
    Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of biphenotypic blast crisis of unclassified myeloproliferative disorder.
    Kim J; Park CJ; Seo EJ; Lee JH; Yoo SJ; Choi SJ; Chi HS
    Ann Hematol; 2002 Oct; 81(10):603-4. PubMed ID: 12424544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature.
    Aguayo A; Cortes JE; Kantarjian HM; Beran M; Gandhi V; Plunkett W; Kurtzberg J; Keating MJ
    Cancer; 1999 Jan; 85(1):58-64. PubMed ID: 9921974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D
    Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
    Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
    Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
    Smith MR; Mohamed AN; Karanes C
    Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-lymphoid extramedullary (lymphadenopathic) blast crisis in CML.
    Van Dorpe J; Van Damme S; Jacobs V; Van den Berghe H; Criel A; Michielssen P; Louwagie A
    Acta Clin Belg; 1995; 50(2):121-5. PubMed ID: 7597876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
    Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
    Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.
    Gao X; Li J; Wang L; Lin J; Jin H; Xu Y; Wang N; Zhao Y; Liu D; Yu L; Wang Q
    Am J Case Rep; 2016 Oct; 17():793-798. PubMed ID: 27784881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of chronic myelocytic leukemia in blast crisis: the myeloblasts became overt from lymphoid and myeloid mixed population of the blast crisis cells after chemotherapy.
    Ikeda T; Kawakami K; Anazawa H; Furuta I; Otsuji N; Miwa H; Ohno T; Kita K; Shirakawa S
    Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):62-9. PubMed ID: 2330807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of 30 cases of chronic myeloid leukemia with non-myeloid blast crisis].
    Ge CW; Li DG; Hao YM
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):731-3, 768. PubMed ID: 2636091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.